In a session starting at 12:45 p.m. ET, Jennifer Green, MD, will discuss some of the factors that may give clinicians second thoughts about initiating these two classes of drugs.
Up next: Experts to weigh starting SGLT2 inhibitors and GLP-1 receptor agonists in the hospital
